GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and Bcl-2 in a murine myeloid cell line M

Blood

Volumn 95, Issue 4, 2000, Pages 1264-1273

  Tanaka, Hirokazu ^b   Matsumura, Itaru ^a   Nakajima, Koichi ^b   Daino, Hanako ^b   Sonoyama, Junko ^b   Yoshida, Hitoshi ^b   Oritani, Kenji ^b   Machii, Takashi ^b   Yamamoto, Masayuki ^b   Hirano, Toshio ^b   Kanakura, Yuzuru ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; INTERLEUKIN 6; PROTEIN BCL 2; PROTEIN KINASE; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0034651544     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1264.004k09_1264_1273     Document Type: Article

References (51)

1. Hirano T. Interleukin 6 and its receptor: ten years later. Intern Rev Immunol. 1998;16:249.
2. Hirano T. Interleukin-6. In: Thomson A., ed. The Cytokine Handbook. 3rd ed. San Diego, Ca: Academic Press; 1998;197.
3. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hematopoietic progenitors. Proc Natl Acad Sci U S A. 1987;84:9035.
4. Van Damme J, Opdenakker G, Simpson RJ, et al. Identification of the human 26-kDa protein, interferon β2 (IFNβ2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med. 1987;165:914.
5. Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and essential requirement of BSF-2/ IL-6 for human multiple myelomas. Nature. 1988; 332:83.
6. Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986;324:73.
7. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P, Burnstein SA. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci U S A. 1989;86:5953.
8. Miyaura C, Onozaki K, Akiyama Y, et al. Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeioid leukemia cells (M1). FEBS Lett. 1988;234:17.
9. Oritani K, Kaisho T, Nakajima K, Hirano T. Retinoic acid inhibits interleukin-6-induced macrophage differentiation and apoptosis in a murine hematopoietic cell line Y6. Blood. 1992;80:2298.
10. Oritani K, Tomiyama Y, Paul WK, et al. Both Sta3-activation and Stat3-independent BCL2 down-regulation are important for IL-6-induced apoptosis of 1A9-M cells. Blood. 1999;93:1346.
11. Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 1997;8:241.
12. Yamanaka Y, Nakajima K, Fukada T, Hibi M, Hirano T. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for STAT3 activation. EMBO J. 1996;15:1557.
13. Nakajima K, Yamanaka Y, Nakae K, et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 1996;15:3651.
14. Minami M, Inoue M, Wei S, et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA. 1996;93:3963.
15. Fukada T, Hibi M, Yamanaka Y, et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity. 1996;5:449.
16. Fukada T, Ohtani T, Yoshida Y, et al. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J. 1998;17:6670.
17. Weiss MJ, Orkin SH. GATA transcription factors: key regulators of hematopoiesis. Exp Hematol. 1995;23:99.
18. Tsai SF, Martin DIK, Zon LI, D'Andrea AD, Wong GG, Orkin SH. Cloning of cDNA for the major DNA binding protein of the erythroid lineage through expression in mammalian cells. Nature. 1989;339:446.
19. Evans T, Felsenfeld G. The erythroid-specific transcription factor eryf1: a new finger protein. Cell. 1989;58:877.
20. Romeo PH, Prandini MH, Joulin V, et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature. 1990;344:447.
21. Martin DI, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 1990;344:444.
22. Ito E, Toki T, Ishihara H, et al. Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature. 1993;362:466.
23. Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 1990;4:1650.
24. Penvy L, Simon MC, Roberison E, et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349:257.
25. Weiss MJ, Orkin SH. Novel insights into erythroid differentiation revealed through differentiation of GATA-1-embryonic stem cells. Genes Dev. 1994; 8:1184.
26. Weiss MJ, Orkin SH. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A. 1995;92:9623.
27. Shivdasani RA, Fujiwara Y, McDevitt M, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 1997;16:3965.
28. Takahashi S, Komeno T, Suwabe N, et al. Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cell in vivo. Blood. 1998;92:434.
29. Kulessa H, Frampton J, Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 1995;9:1250.
30. Visvader JE, Elefanty AG, Strasser A, Adams JM. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid cell line. EMBO J. 1992;11:4557.
31. Yamaguchi Y, Zon LI, Ackerman SJ, Yamamoto M, Suda T. Forced GATA-1 expression in the murine myeloid cell line M1: induction of C-Mpl expression and megakaryocytic/erythroid differentiation. Blood. 1998;91:450.
32. Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J Cell Physiol. 1969;74:223.
33. Horikawa Y, Matsumura I, Hashimoto K, et al. Markedly reduced expression of platelet c-mp/ receptor in essential tnrombocythemia. Blood. 1997;90:4031.
34. Matsumura I, Nakajima K, Wakao H, et al. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol. 1998;18:4282.
35. Matsumura I, Kanakura Y, Kato T, et al. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood. 1995; 86:703.
36. Matsumura I, Kanakura Y, Kato T, et al. The biological properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood. 1996;88:3074.
37. Matsumura I, Ishikawa J, Nakajima K, et al. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line CMK involves transcriptional activation of p21WAF1/ Cip1 by STAT5. Mol Cell Biol. 1997;17:2933.
38. Wegenka UM, Buschmann J, Lutticken C, Heinlich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response element, is rapidly activated by interteukin-6 at the posttranscriptional level. Mol Cell Biol. 1993;13:276.
39. Nakajima K, Wall R. Interleukin-6 signals activating jun B and TIS11 gene transcription in a B-cell hybridoma. Mol Cell Biol. 1991;11:1409.
40. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149.
41. NK4D with IL-6-induced growth arrest. Biochem Biophys Res Commun. 1997;238:764.
42. Dubart A, Romeo PH, Vainchenker W, Dumenil D. Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood. 1996;87:3711.
43. Whyatt DJ, Karis A, Harkes IC, et al. The levels of the tissue-specific factor GATA-1 affects the cell-cyclo machinery. Genes Funct. 1997;1:11.
44. Kikuchi J. Furukawa Y. Iwase S, et al. Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: involvement of cyclin-dependent kinase inhibitor p21 in polyploidization. Blood. 1997;89:3980.
45. Adachi M, Roussel MF, Havenith K, Sherr CJ. Features of macrophage differentiation induced by p191NK4D, a specific inhibitor of cyclin D-dependent kinases. Blood. 1997;90:126.
46. INK4C and IL-6. Immunity. 1997;6:47.
47. Kato J, Sherr CJ. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci USA. 1993;90:11513.
48. Kiyokawa H, Richon VM, Rifkind RA, Marks PA. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol. 1994;14:7195.
49. Field SJ, Tsai F-Y, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 1996;85:549.
50. Shimamoto T, Nakamura S, Bollekens J, Ruddle FH, Takeshita K. Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis. Proc Natl Acad Sci U S A. 1997;94:3245.
51. Yamada T, Kihara-Negishi F, Yamamoto H, Yamamoto M, Hashimoto Y, Oikawa T. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells. Exp Cell Res. 1998;245:186.